Each publication is assigned a series of tags by the author(s) and the librarians at NLM. These are known as MESH (MEdical Subject Heading) terms. These tags are then use by the Colorado Research Mine to create a web of related experts.
As more publication databases are added to the Colorado Research Mine there will be more tags from which to choose.
This page offers three methods for finding experts from the University of Colorado at Denver and Health Sciences Center School of Medicine:
Click on MESH term to find faculty publications associated with the term. Total number for this letter:
228
| MESH Term |
Number of Times Used by Faculty Group |
| Iatrogenic Disease |
2 |
| Ice |
1 |
| I-kappa B Kinase |
3 |
| I-kappa B Proteins |
2 |
| Iliac Artery |
1 |
| Illinois |
1 |
| Image Enhancement |
1 |
| Image Interpretation, Computer-Assisted |
2 |
| Image Processing, Computer-Assisted |
37 |
| Imaging, Three-Dimensional |
16 |
| Imitative Behavior |
1 |
| Immediate-Early Proteins |
1 |
| Immediate-Early Proteins/metabolism |
1 |
| Immobilization |
1 |
| Immune Tolerance |
6 |
| Immunity |
3 |
| Immunity, Cellular |
6 |
| Immunity, Maternally-Acquired |
1 |
| Immunity, Mucosal |
1 |
| Immunity, Natural |
10 |
| Immunization |
19 |
| Immunization Programs |
2 |
| Immunization Schedule |
2 |
| Immunization, Passive |
1 |
| Immunization, Secondary |
4 |
| Immunization/utilization |
1 |
| Immunoassay |
1 |
| Immunoblotting |
21 |
| Immunochemistry |
4 |
| Immunocompetence |
2 |
| Immunocompromised Host |
9 |
| Immunoconjugates |
2 |
| Immunoenzyme Techniques |
16 |
| Immunoglobulin A |
1 |
| Immunoglobulin G |
1 |
| Immunoglobulin Joining Region/genetics |
1 |
| Immunoglobulin Variable Region/genetics |
1 |
| Immunoglobulins, Intravenous |
1 |
| Immunoglobulins/biosynthesis |
1 |
| Immunohistochemistry |
120 |
| Immunologic Deficiency Syndromes |
1 |
| Immunologic Memory |
9 |
| Immunologic Surveillance |
1 |
| Immunologic Techniques |
2 |
| Immunologic Tests |
2 |
| Immunophenotyping |
22 |
| Immunoprecipitation |
11 |
| Immunosuppression |
6 |
| Immunosuppressive Agents/adverse effects |
1 |
| Immunosuppressive Agents/therapeutic use |
1 |
| Immunotherapy |
15 |
| Immunotherapy, Active |
1 |
| Immunotherapy, Adoptive |
10 |
| Impulsive Behavior |
1 |
| In Situ Hybridization |
12 |
| In Situ Hybridization, Fluorescence |
28 |
| In Situ Nick-End Labeling |
7 |
| In Vitro |
58 |
| Inbreeding |
1 |
| Incidence |
115 |
| Incidental Findings |
1 |
| Income |
12 |
| India |
7 |
| Indians, North American |
21 |
| Indians, North American/psychology |
2 |
| Indians, South American |
1 |
| Indicator Dilution Techniques |
2 |
| Indicators and Reagents |
6 |
| Individuality |
1 |
| Indocyanine Green |
1 |
| Indoleamine-Pyrrole 2,3,-Dioxygenase |
1 |
| Indoles |
2 |
| Industry |
1 |
| Infant Behavior |
1 |
| Infant Care |
1 |
| Infant Food |
6 |
| Infant Formula |
1 |
| Infant Mortality |
1 |
| Infant Nutrition |
8 |
| Infant Welfare |
4 |
| Infant, Low Birth Weight |
2 |
| Infant, Newborn, Diseases |
1 |
| Infant, Premature |
26 |
| Infant, Small for Gestational Age |
2 |
| Infant, Very Low Birth Weight |
8 |
| Infection Control |
2 |
| Infection Control/organization & administration |
1 |
| Inflammation |
25 |
| Influenza Vaccines |
3 |
| Influenza Vaccines/adverse effects |
1 |
| Influenza, Human |
2 |
| Influenza, Human/prevention & control |
1 |
| Information Dissemination |
4 |
| Information Services |
8 |
| Information Storage and Retrieval |
3 |
| Information Systems |
1 |
| Information Theory |
1 |
| Informed Consent |
9 |
| Infusion Pumps |
1 |
| Infusion Pumps, Implantable |
2 |
| Infusions, Intra-Arterial |
2 |
| Infusions, Intravenous |
33 |
| Infusions, Parenteral |
4 |
| Inhalation Spacers |
1 |
| Inhibition (Psychology) |
4 |
| Inhibitor of Apoptosis Proteins |
1 |
| Inhibitory Concentration 50 |
15 |
| Injections |
5 |
| Injections, Intra-Arterial |
2 |
| Injections, Intradermal |
1 |
| Injections, Intralesional |
1 |
| Injections, Intramuscular |
6 |
| Injections, Intraperitoneal |
2 |
| Injections, Intravenous |
19 |
| Injections, Intraventricular |
1 |
| Injections, Spinal |
1 |
| Injections, Subcutaneous |
15 |
| Injury Severity Score |
21 |
| Inpatients |
5 |
| Insect Control |
1 |
| Insects |
2 |
| Institutionalization |
1 |
| Insulin Infusion Systems |
7 |
| Insulin Resistance |
26 |
| Insulin-Like Growth Factor Binding Proteins |
1 |
| Insulin-Like Growth Factor I/metabolism |
1 |
| Insurance Claim Review |
2 |
| Insurance Coverage |
2 |
| Insurance Selection Bias |
1 |
| Insurance, Health |
5 |
| Insurance, Health, Reimbursement |
1 |
| Insurance, Pharmaceutical Services |
1 |
| Integrin alpha3/metabolism |
1 |
| Intelligence |
4 |
| Intelligence Tests |
2 |
| Intensive Care |
4 |
| Intensive Care Units |
9 |
| Intensive Care Units, Neonatal |
3 |
| Intensive Care Units, Pediatric |
3 |
| Intensive Care, Neonatal |
1 |
| Intercellular Signaling Peptides and Proteins |
4 |
| Intercellular Signaling Peptides and Proteins/metabolism |
1 |
| Interdisciplinary Communication |
1 |
| Interferometry |
2 |
| Interferon Alfa-2a |
1 |
| Interferon Regulatory Factor-3 |
2 |
| Interferon Regulatory Factor-7 |
2 |
| Interferon Type II |
4 |
| Interferon Type II/biosynthesis |
1 |
| Interferon Type II/metabolism |
2 |
| Interferon Type II/pharmacology |
1 |
| Interferon-Stimulated Gene Factor 3 |
1 |
| Interferon-Stimulated Gene Factor 3, gamma Subunit |
1 |
| Intergenerational Relations |
4 |
| Interinstitutional Relations |
4 |
| Interleukin-1 |
2 |
| Interleukin-10 |
1 |
| Interleukin-10/genetics |
1 |
| Interleukin-10/therapeutic use |
1 |
| Interleukin-12/metabolism |
1 |
| Interleukin-13/biosynthesis |
1 |
| Interleukin-18 |
3 |
| Interleukin-18/blood |
1 |
| Interleukin-18/pharmacology |
2 |
| Interleukin-2 |
1 |
| Interleukin-3/pharmacology |
1 |
| Interleukin-4/biosynthesis |
2 |
| Interleukin-4/genetics |
1 |
| Interleukin-4/immunology |
1 |
| Interleukin-4/metabolism |
2 |
| Interleukin-4/physiology |
3 |
| Interleukin-5/metabolism |
1 |
| Interleukin-6 |
2 |
| Interleukin-8 |
1 |
| Internal Fixators |
2 |
| Internal Mammary-Coronary Artery Anastomosis |
1 |
| Internal Medicine |
2 |
| Internal-External Control |
2 |
| International Classification of Diseases |
4 |
| International Cooperation |
2 |
| International Normalized Ratio |
3 |
| Internet |
15 |
| Internship and Residency |
19 |
| Interpersonal Relations |
15 |
| Interprofessional Relations |
6 |
| Intervention Studies |
16 |
| Interview, Psychological |
3 |
| Interviews |
30 |
| Intestinal Absorption |
8 |
| Intestine, Small |
1 |
| Intra-Aortic Balloon Pumping |
1 |
| Intracellular Signaling Peptides and Proteins |
11 |
| Intracellular Signaling Peptides and Proteins/metabolism |
2 |
| Intracranial Arterial Diseases |
1 |
| Intracranial Pressure |
1 |
| Intracranial Thrombosis |
1 |
| Intraocular Pressure |
2 |
| Intraoperative Care |
3 |
| Intraoperative Complications |
1 |
| Intraoperative Period |
1 |
| Introns |
4 |
| Intubation, Gastrointestinal |
2 |
| Intubation, Intratracheal |
3 |
| Inuits |
4 |
| Inversion, Chromosome |
1 |
| Investments |
1 |
| Iodine Radioisotopes |
2 |
| Ion Channel Gating |
2 |
| Ion Channels |
2 |
| Ions |
1 |
| Iontophoresis |
1 |
| Iris Neoplasms |
1 |
| Iron-Sulfur Proteins |
2 |
| Irrigation |
1 |
| Irritable Mood |
1 |
| Ischemia |
2 |
| Islam |
1 |
| Islets of Langerhans Transplantation |
1 |
| Islets of Langerhans Transplantation/immunology |
1 |
| Isoelectric Focusing |
1 |
| Isoelectric Point |
1 |
| Isomerism |
1 |
| Isometric Contraction |
2 |
| Isoniazid |
2 |
| Isoniazid/adverse effects |
1 |
| Isoniazid/therapeutic use |
1 |
| Isotope Labeling |
3 |
| Italy |
2 |
